Quick Takeaways
- This page summarizes James P. Mackin's Form 4 filing for ARTIVION, INC. (AORT).
- 4 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 01 Mar 2023, 17:36.
James P. Mackin - 23 Feb 2023 Form 4 Insider Report for ARTIVION, INC. (AORT)
- Role
- President & CEO
- Signature
- /s/ James P Mackin
- Issuer symbol
- AORT
- Transactions as of
- 23 Feb 2023
- Net transactions value
- -$292,787
- Form type
- 4
- Filing time
- 01 Mar 2023, 17:36:48 UTC
- Previous filing
- 21 Feb 2023
- Next filing
- 03 Mar 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"James P. Mackin filed Form 4 for ARTIVION, INC. (AORT) on 01 Mar 2023."
What Changed
- Previous filing in this sequence was filed on 21 Feb 2023.
- Current net transaction value: -$292,787.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Award | $0 | +28,282 | +5.7% | $0.000000 | 520,534 | 23 Feb 2023 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $163,601 | -12,645 | -2.4% | $12.94 | 507,889 | 27 Feb 2023 | Direct | F2 |
| transaction | AORT | Common Stock | Award | $0 | +42,148 | +8.3% | $0.000000 | 550,037 | 23 Feb 2023 | Direct | F3 |
| transaction | AORT | Common Stock | Sale | $129,186 | -9,985 | -1.8% | $12.94 | 540,052 | 27 Feb 2023 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023. |
| F2 | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
| F3 | Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date. |